Davidson Kahn Capital Management, LLC
Position in IBRX — ImmunityBio, Inc.
CIK 2055535
SHERMAN OAKS, CA
Position in IBRX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,427,870
New position
Shares Held
163,092
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#86
of 394 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Davidson Kahn Capital Management, LLC holds $1,638,620 across 2 Biotechnology names. IBRX ranks #1 (87.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
This page
|
163,092 | $1,427,870 | |
| 2 | EXOZ |
Exozymes Inc.
|
25,000 | $210,750 |
All Filings in IBRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,427,870 | 163,092 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||